ABCC1 and ovarian cancer: Furthermore, HA treatment significantly increased the expression of the ATP-binding cassette (ABC) drug transporters (ABCB3, ABCC1, ABCC2, and ABCC3), but only in ovarian cancer cells expressing CD44 (47).